DE102011003101B4 - Verfahren zum Nachweis einer Plasmodieninfektion - Google Patents

Verfahren zum Nachweis einer Plasmodieninfektion Download PDF

Info

Publication number
DE102011003101B4
DE102011003101B4 DE102011003101.4A DE102011003101A DE102011003101B4 DE 102011003101 B4 DE102011003101 B4 DE 102011003101B4 DE 102011003101 A DE102011003101 A DE 102011003101A DE 102011003101 B4 DE102011003101 B4 DE 102011003101B4
Authority
DE
Germany
Prior art keywords
plasmodium
sample
infection
distribution
parameters
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE102011003101.4A
Other languages
German (de)
English (en)
Other versions
DE102011003101A1 (de
Inventor
Dr. Hayden Oliver
Jan van den Boogaart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics Products GmbH
Original Assignee
Siemens Healthcare Diagnostics Products GmbH
Siemens Healthcare Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to DE102011003101.4A priority Critical patent/DE102011003101B4/de
Application filed by Siemens Healthcare Diagnostics Products GmbH, Siemens Healthcare Diagnostics Inc filed Critical Siemens Healthcare Diagnostics Products GmbH
Priority to PCT/EP2011/073428 priority patent/WO2012084963A1/de
Priority to CN201180068461.7A priority patent/CN103392005B/zh
Priority to ES11811341T priority patent/ES2530357T3/es
Priority to EP11811341.4A priority patent/EP2635695B1/de
Priority to JP2013545314A priority patent/JP5657813B2/ja
Priority to CN201711089537.XA priority patent/CN107815485B/zh
Priority to US13/996,948 priority patent/US9605293B2/en
Publication of DE102011003101A1 publication Critical patent/DE102011003101A1/de
Application granted granted Critical
Publication of DE102011003101B4 publication Critical patent/DE102011003101B4/de
Priority to US15/449,859 priority patent/US20170175162A1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10—Investigating individual particles
    • G01N15/14—Optical investigation techniques, e.g. flow cytometry
    • G01N15/1456—Optical investigation techniques, e.g. flow cytometry without spatial resolution of the texture or inner structure of the particle, e.g. processing of pulse signals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/01—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials specially adapted for biological cells, e.g. blood cells
    • G01N2015/016—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/01—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials specially adapted for biological cells, e.g. blood cells
    • G01N2015/018—Platelets
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/44—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from protozoa
    • G01N2333/445—Plasmodium
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Dispersion Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE102011003101.4A 2010-12-23 2011-01-25 Verfahren zum Nachweis einer Plasmodieninfektion Active DE102011003101B4 (de)

Priority Applications (9)

Application Number Priority Date Filing Date Title
DE102011003101.4A DE102011003101B4 (de) 2010-12-23 2011-01-25 Verfahren zum Nachweis einer Plasmodieninfektion
CN201180068461.7A CN103392005B (zh) 2010-12-23 2011-12-20 检测疟原虫感染的方法
ES11811341T ES2530357T3 (es) 2010-12-23 2011-12-20 Método para detectar una infección con plasmodio
EP11811341.4A EP2635695B1 (de) 2010-12-23 2011-12-20 Verfahren zum Nachweis einer Plasmodieninfektion.
PCT/EP2011/073428 WO2012084963A1 (de) 2010-12-23 2011-12-20 Verfahren zum nachweis einer plasmodieninfektion
JP2013545314A JP5657813B2 (ja) 2010-12-23 2011-12-20 プラスモジウム感染の検出方法
CN201711089537.XA CN107815485B (zh) 2010-12-23 2011-12-20 检测疟原虫感染的方法
US13/996,948 US9605293B2 (en) 2010-12-23 2011-12-20 Method for detecting a plasmodium infection
US15/449,859 US20170175162A1 (en) 2010-12-23 2017-03-03 Method for detecting a plasmodium infection

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102010064131 2010-12-23
DE102010064131.6 2010-12-23
DE102011003101.4A DE102011003101B4 (de) 2010-12-23 2011-01-25 Verfahren zum Nachweis einer Plasmodieninfektion

Publications (2)

Publication Number Publication Date
DE102011003101A1 DE102011003101A1 (de) 2012-06-28
DE102011003101B4 true DE102011003101B4 (de) 2016-04-07

Family

ID=45524485

Family Applications (1)

Application Number Title Priority Date Filing Date
DE102011003101.4A Active DE102011003101B4 (de) 2010-12-23 2011-01-25 Verfahren zum Nachweis einer Plasmodieninfektion

Country Status (7)

Country Link
US (2) US9605293B2 (enExample)
EP (1) EP2635695B1 (enExample)
JP (1) JP5657813B2 (enExample)
CN (2) CN107815485B (enExample)
DE (1) DE102011003101B4 (enExample)
ES (1) ES2530357T3 (enExample)
WO (1) WO2012084963A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102013203839B4 (de) 2013-03-06 2014-10-16 Siemens Healthcare Diagnostics Products Gmbh Verfahren zur Analyse einer Blutprobe und zugehöriges Hämatologie-System
DE102013216362A1 (de) * 2013-08-19 2015-02-19 Siemens Healthcare Diagnostics Products Gmbh Analyseverfahren zur Klassifikationsunterstützung
DE102014200911A1 (de) * 2013-10-09 2015-04-09 Siemens Aktiengesellschaft In-Vitro-Verfahren zum markierungsfreien Bestimmen eines Zelltyps einer Zelle
EP3462170B1 (en) * 2017-09-29 2020-09-16 Siemens Healthcare GmbH Specific malaria detection with digital optical microscopy
CN111781248A (zh) * 2020-07-15 2020-10-16 浙江师范大学 一种疟疾检测装置

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6025A (en) * 1849-01-09 Island
US5045472A (en) 1981-06-26 1991-09-03 Technicon Instruments Corporation Reagent mixture and composition for treating red blood cells to effect sphering
US5284771A (en) * 1991-12-05 1994-02-08 Miles Inc. Reagent compositions and their use in sphering cells
US5888752A (en) * 1995-05-16 1999-03-30 Bayer Corporation Universal rinse reagent and method for use in hematological analyses of whole blood samples
US6114173A (en) 1997-04-03 2000-09-05 Bayer Corporation Fully automated method and reagent composition therefor for rapid identification and characterization of reticulocytes erythrocytes and platelets in whole blood
EP1718966B1 (en) * 2004-02-27 2013-04-24 Beckman Coulter, Inc. Method for detection of malaria and other parasite infections
US7580120B2 (en) 2005-04-07 2009-08-25 Sysmex Corporation Blood analyzer, sample analyzer, and flow cytometer
CN102016577B (zh) 2008-05-09 2015-06-17 希森美康株式会社 血液分析装置,血液分析方法及溶血剂

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CAMPUZANO-ZULUAGA, G. u.a.: Automated haematology analysis to diagnose malaria. Malar. J. (30.11.2010) 9:346 *

Also Published As

Publication number Publication date
US9605293B2 (en) 2017-03-28
CN107815485A (zh) 2018-03-20
CN103392005A (zh) 2013-11-13
US20170175162A1 (en) 2017-06-22
JP2014506323A (ja) 2014-03-13
DE102011003101A1 (de) 2012-06-28
CN107815485B (zh) 2021-05-18
ES2530357T3 (es) 2015-03-02
EP2635695B1 (de) 2015-01-28
WO2012084963A1 (de) 2012-06-28
JP5657813B2 (ja) 2015-01-21
US20130337496A1 (en) 2013-12-19
CN103392005B (zh) 2017-12-08
EP2635695A1 (de) 2013-09-11

Similar Documents

Publication Publication Date Title
DE3855919T2 (de) System zur Isolierung und Identifizierung von Leukozyten
DE69924968T2 (de) Verfahren zum unterscheiden von kernhaltigen roten blutzellen
DE3853671T2 (de) Reagens und Verfahren zur Messung von Leukozyten und Hämoglobin im Blut.
JP2565844B2 (ja) 細胞溶解処理条件下で異種細胞集団を正確に計数し，感受性に関する格付けを行う方法
DE69211434T2 (de) Verfahren zur Probevorbereitung zur Klassifizierung und Zählung der Leukozyten
DE69621459T2 (de) Reagens und verfahren zur differentiellen bestimmung von leukozyten im blut
DE3786233T2 (de) Durchfluss-Zytometrieverfahren zum Klassifizieren von Leukozyten und dazu angewandte Reagenzien.
EP2635695B1 (de) Verfahren zum Nachweis einer Plasmodieninfektion.
DE69927871T2 (de) Vorrichtung und Verfahren zur Unterscheidung von Erythrozyten in Urin
DE69701446T2 (de) Verfahren und vorrichtung zur bestimmung des hämoglobingehalts von einzelnen roten blutkörperchen
US20240353311A1 (en) Blood cell analyzer, method and use of infection marker parameter
Qazi et al. Screening for beta thalassemia trait
Schaefer et al. The clinical relevance of nucleated red blood cell counts
US20210110545A1 (en) Method of obtaining an indicator of patient sepsis and apparatus for such a method
Bawah et al. Hematological profile of children under five years with malaria at the Ho Municipality of Ghana
US20240361231A1 (en) Blood cell analyzer, method for indicating intection status and use of infection marker parameter
DE69931613T2 (de) Verfahren zum Zählen von Leukozyten und Leukozytenzähler
US20100120081A1 (en) High sensitivity parameters for the detection of vitamin b12 and/or folate deficiencies and methods of use
EP2291658B1 (de) Durchflusszytometrisches verfahren zur bestimmung von gesamtleukozytenzahl und trombozytenzahl sowie zur leukozytendifferenzierung in blutproben von vögeln
Klenner et al. Myeloperoxidase deficiency in dogs observed with the ADVIA® 120
Ibrhim Cow, sheep and goat hematological parameters: Comparative studies between automated analyzer and manual methods
US20240353310A1 (en) Blood cell analyzer, method for indicating infection status and use of infection marker parameter
Ratnaningsih et al. Schistocytes Evaluation in Iron Deficiency: An Assessment Adopted From ICSH Nomenclature Guideline
Ali El-Banhawy et al. Relationship between Peripheral Blood Cytopenia and Type 2 Diabetic Patients in Benha University Hospital
CN120195081A (zh) 血液细胞分析仪以及用于评估受试者的感染状态的方法

Legal Events

Date Code Title Description
R012 Request for examination validly filed
R081 Change of applicant/patentee

Owner name: SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH, DE

Free format text: FORMER OWNER: SIEMENS AKTIENGESELLSCHAFT, 80333 MUENCHEN, DE

Effective date: 20150120

R016 Response to examination communication
R018 Grant decision by examination section/examining division
R020 Patent grant now final